QCG
ARKG icon

Quadrant Capital Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Quadrant Capital Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-600
Closed -$12.5K – 1414
2025
Q1 		$12.5K Sell
600
-400
-40% -$10K ﹤0.01% 2163
2024
Q4 		$23.5K Hold
1,000
– – ﹤0.01% 1817
2024
Q3 		$25.6K Hold
1,000
– – ﹤0.01% 1790
2024
Q2 		$23.5K Hold
1,000
– – ﹤0.01% 1777
2024
Q1 		$28.8K Hold
1,000
– – ﹤0.01% 1685
2023
Q4 		$32.8K Hold
1,000
– – ﹤0.01% 1588
2023
Q3 		$27.9K Buy
+1,000
New +$32.7K ﹤0.01% 1553

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quadrant Capital Group's ARKG Position: Q2 2025 in Review

Quadrant Capital Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 600 shares — an estimated $12.5K sold.

Quadrant Capital Group first reported a position in ARKG in Q3 2023 and held it in 7 quarters. The position peaked at $32.8K in Q4 2023. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

  • Quadrant Capital Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 600 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $12.5K.
  • Quadrant Capital Group first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 7 quarters.
  • Quadrant Capital Group's ARK Genomic Revolution ETF position peaked at $32.8K in Q4 2023.
  • 213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Quadrant Capital Group's 13F filing for Q2 2025, filed 13 Aug 2025.